Abstract:LCAD is a mitochondrial flavoenzyme encoded on nuclear genome which catalizes the first reaction in fatty acid beta-oxidation. We characterized 2 kb of upstream 5′-flanking region of the human LCAD gene by sequence analysis. This promoter region lacks TATA or CAAT boxes, is extremely GC-rich, contains SP1 binding sites, and has several nuclear response element (NRRE) consensus hexamers. Chimeric plasmids containing various 5′-flanking genomic fragments fused upstream of the chloramphenicol acetyl transferase(CAT) reporter gene were transfected into human hepatoma cells, neonatal rat cardiomyocytes, and mouse 3T3 fibroblast cells. Minimal promoter is -200 to +1 upstream of the Cap site. Two suppressor sequences, at -288 to -259, and -1048 to -1010 respectively, both contain two NRRE consensus binding sites, and interact with COUP-TF on gel shift analysis. To further define the promoter region of the human LCAD gene by transgenic mouse analysis, constructs containing the LCAD 5′-flanking regions, -1,800/+1 and -200/+1, linked with luciferase reporter gene excised from pT3/T7-LUC luciferase expression vector were micro-injected into mouse oocytes by standard techniques. Founder animals incorporating the LCAD-luciferase chimeric gene identified by PCR and tail DNA blot experiments were bred with normal C57BL/6J mice. F1 mice positive for the incorporated LCAD-luciferase fusion gene have been tested for expression by luciferase assay from various tissue extracts, and immunohistochemistry. Distribution of luciferase activity in various tissues of progeny of the human LCAD -200 or -1800/ luciferase indicated LCAD -200/+1 region contains an active promoter with some tissue specification; -1800/+1 region contains suppressor element. Thus, both in vitro andin vivo studies showed that LCAD NRRE-281 and LCAD NRRE-1032 contain suppressor activity, and LCAD -200/+1 contains promoter function with some tissue specificity. Funded by NIH grant #PO1-DK33487.

Cloning and Characterization of a Human Cdna ACAD10 Mapped to Chromosome 12Q24.1

Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family.

Cloning and characterization of the human soluble adenylyl cyclase.

Cloning and Characterization of A Novel Human Alcohol Dehydrogenase Gene (Adhfe1)

[Cloning and Identification of a New Telomeric-Associated Zinc Finger Protein Cdna].

Structural Organization and Regulatory Regions of the Human Medium-Chain Acyl-Coa Dehydrogenase Gene

Cloning and Characterization of a Novel Human Homolog* of Mouse U26, a Putative PQQ-dependent AAS Dehydrogenase

Cloning and Expression of a Novel Human C5orf12 Gene*, a Member of the TMS_TDE Family.

Dynamic Modelling of an ACADS Genotype in Fatty Acid Oxidation – Application of Cellular Models for the Analysis of Common Genetic Variants

Cloning,Expression and Activity Analysis of Two Kinds ACADs in Cyprinus carpio

Novel ACADVL Variants Resulting in Mitochondrial Defects in Long-Chain Acyl-Coa Dehydrogenase Deficiency.

Cloning And Characterization A Novel Human 1-Acyl-Sn-Glycerol-3-Phosphate Acyltransferase Gene Agpat7

Molecular Cloning and Expression Analysis of a New Gene for Short-Chain Dehydrogenase/reductase 9.

IN VIVO AND IN VITRO ANALYSIS OF THE HUMAN LONG CHAIN ACYL COA DEHYDROGENASE(LCAD) GENE PROMOTER REGION. † 889

Cloning and Characterization of a Novel Human Pantothenate Kinase Gene

Regulation of the Human Long Chain Acyl-Coa Dehydrogenase Gene by Nuclear Hormone Receptor Transcription Factors

Cloning And Characterization Of Human Synaptotagmin 10 Gene

A New Genetic Disorder in Mitochondrial Fatty Acid β-Oxidation: ACAD9 Deficiency

Molecular Cloning and Characterization of CT120, a Novel Membrane-Associated Gene Involved in Amino Acid Transport and Glutathione Metabolism.

Characterization of the Human Very-Long-Chain Acyl-CoA Dehydrogenase Gene Promoter Region: A Role for Activator Protein 2

Cloning, Expression and Mapping of the Full-Length Cdna of Human CCTβ Subunit